28 November - 18 December 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Encouraging stem cell results
Treatment of people with progressive MS with mesenchymal stem cells from their own bone marrow led to about half of the participants not experiencing any disease activity in the following year, according to an Israeli study. Unlike AHSCT (another type of stem cell treatment) the Israeli approach requires repeat treatments to remain effective.
In a different study in the USA, mesenchymal stem cell treatment reduced or reverse disability progression in three quarters of people with progressive MS. People who were more disabled at the start of the trial were more likely to see the benefits wear off after two years.
MS Trust link: Stem cell treatment
Getting through homeschooling with MS
20 Jan 2021 - 00:00
In her latest blog for the MS Trust, Carla King looks at how to cope with homeschooling when you have MS.
MS in the Media
15 Jan 2021 - 00:00
- Covid vaccine advice for people with MS
- Potential MS vaccine in early trials
- Long-term benefits of DMDs studied
- Sunlight exposure and MS
Researchers develop mRNA vaccine to treat MS-like condition in mice
14 Jan 2021 - 00:00
A potential treatment for multiple sclerosis uses mRNA technology, similar to two of the Covid-19 vaccines. Find out more about this research.